Vestibular and auditory disorders

Current Opinion in Neurology

Volumn 9, Issue 1, 1996, Pages 32-36

  Baloh, Robert W ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPORT SYNDROME; GENE; GENE LOCUS; HEARING DISORDER; HEARING IMPAIRMENT; HEREDITARY ATAXIA; HUMAN; NYSTAGMUS; PATHOPHYSIOLOGY; SHORT SURVEY; STAPES; USHER SYNDROME; VERTIGO; VESTIBULAR DISORDER;

EID: 0029879227     PISSN: 13507540     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019052-199602000-00007     Document Type: Short Survey

References (24)

1. McClure JA, Parnes LS: A cure for benign positional vertigo. Baillière's Clinical Neurology 1994, 3:537-545. McClure and Parnes reviewed the pathophysiology of benign positional vertigo and discuss the theoretical basis for the positional maneuvers. They describe three patients who developed horizontal canal benign positional vertigo after being treated with the particle repositioning maneuver for posterior canal benign positional vertigo.
2. Epley JM: Positional vertigo related to semicircular canalithiasis. Otolaryngol Head Neck Surg 1995, 112:154-161. Epley reviews his extensive experience in treating benign positional vertigo with the particle repositioning maneuver. He emphasizes the importance of vibration applied to the mastoid bone during the maneuver.
3. Brandt T, Steddin S, Eng D. Daroff RB: Therapy for benign paroxysmal positioning vertigo, revisited. Neurology 1994, 44: 796-800. This review article summarizes the latest information regarding the pathophysiology of benign positional vertigo and the different positional maneuvers that have been used to treat it.
4. Harvey SA, Hain TC, Adamiec LC: Modified liberatory maneuver effective treatment for benign paroxysmal positional vertigo. Laryngoscope 1994, 104:1206-1212.
5. Welling DB, Barnes DE: Particle repositioning maneuver for benign paroxysmal positional vertigo. Laryngoscope 1994, 104:946-949.
6. Fife TD: Bedside cure for benign positional vertigo. BNI Quarterly 1994, 10:2-8. This review contains excellent illustrations explaining the characteristics of the positional nystagmus and demonstrating how to perform the particle repositioning maneuver.
7. Li JC: Mastoid oscillation: a critical factor for success in the canalith repositioning procedure. Otolaryngol Head Neck Surg 1995, 112: 670-675.
8. de Kok YJM, van der Maarel SM, Bitner-Glindzicz M, Huber I, Monaco AP, Malcolm S, Pembrey ME, Ropers HH, Cremers FP: Association between X-linked mixed deafness and mutations in the POU domain gene POU3F4. Science 1995, 267:685-688. This is a first report of a mutation in one of the POU domain genes which are critical in the development of the inner ear. The mutation results in deafness with fixation of the stapes, the most common X-linked form of hearing.
9. Guilford P, Ayadia H, Blanchard S, Chaib H, Le Paslier D, Weissenbach J, Drira M, Petit C: A human gene responsible for neurosensory, non-syndromic recessive deafness is a candidate homologue of the mouse sh-1 gene. Hum Molec Genet 1994, 3:989-993.
10. Chaib H, Lina-Granade G, Guilford P, Plauchu H, Levilliers J, Morgan A, Petit C: A gene responsible for a dominant form of neurosensory non-syndromic deafness maps to the NSRD1 recessive deafness gene interval. Hum Molec Gene 1994, 3:2219-2222.
11. Guilford P, Ben Arab S, Blanchard S, Levilliers J, Weissenbach J, Belkahia A, Petit C: A non-syndrome form of neurosensory, recessive deafness maps to the pericentromeric region of chromosome 13q. Nature Genet 1994, 624-28.
12. Coucke P, Van Camp G, Djoyodiharjo B, Smith SD, Frants RR, Padberg GW, Darby JK, Huizing EH, Cremers CW, Kimberling WJ et al.: Linkage of autosomal dominant hearing loss to the short arm of chromosome 1 in two families. N Engl J Med 1994, 331:425-431.
13. Mochizuki T, Lemmink HH, Mariyama M, Antignac C, Gubler MC, Pivson Y, Verellen-Dumoulin C, Chan B, Schroder CH, Smeets HJ et al.: Identification of mutations in the alpha 3(IV) and alpha 4(IV) collagen gennes in autosomal recessive Alport syndrome. Nature Genet 1994, 8:77-81. This report identifies mutations in two different genes for collagen IV in the autosomal recessive form of Alport syndrome. Both the X-linked and recessive form of this disorder have now been shown to be caused by genetic defects in type IV collagen. As type IV collagen is a key component of basement membranes in the inner ear and kidney, this genetic abnormality explains the combined kidney and inner ear disorder.
14. Weil D, Blanchard S, Kaplan J, Guilford R, Gibson F, Walsh J, Mburu P, Varela A, Levilliers J, Weston MD et al.: Defective myosin VIIA gene responsible for usher syndrome type 1b. Nature 1995, 374:60-61. One type of Usher syndrome was found to be caused by a genetic defect in myosin VIIa. As myosin is important for stereocilliary function, defects in this protein can explain the loss of auditory and vestibular function associated with this syndrome.
15. Griggs RC, Nutt JG: Episodic ataxias as channelopathies. Ann Neurol 1995, 37:285-287.
16. Litt M, Kramer P, Browne D, Gancher S, Brunt ER, Root D, Phromchotikul T, Dubay CJ, Nutt J: A gene for episodic ataxia/ myokymia maps to chromosome 12p13. Am J Hum Genet 1994, 55:702-709.
17. Vahedi K, Joutel A, Van Bogaert P, Ducros A, Maciazeck J, Bach JF, Bousser MG, Tournier-Lasserve E: A gene for hereditary paroxysmal cerebellar ataxia maps to chromosome 19p. Ann Neurol 1995, 37:289-293. This is a first report of a chromosomal locus for the gene associated with the variant of familial periodic ataxia associated with interictal nystagmus. Of particular interest, the same genetic locus has been linked to familial hemiplegic migraine and cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy.
18. von Brederlow B, Hahn AF, Koopman WJ, Ebers GC, Bulman DE: Mapping the gene for acetazolamide responsive hereditary paroxysmal cerebellar ataxia to chromosome 19p. Hum Molec Genet 1995, 4:279-284.
19. Kramer P, Yue Q, Gancher ST, Nutt JG, Baloh R, Smith E, Browne D, Bussey K, Lorrien E, Nelson S et al.. A locus for the nystagmus-associated form of episodic ataxia maps to an 11 cM region on chromosome 19p. Amer J Hum Genet 1995, 57:182-185.
20. Browne DL, Gancher ST, Nutt JG, Brunt ER, Smith EA, Kramer P, Litt M: Episodic ataxia/myokymia syndrome is associated with point mutations in the human potassium channel gene, KCNA1. Nature Genet 1994, 8:136-140. This is the first report of a neurologic syndrome resulting from a mutation in a brain potassium channel gene. It is likely that other neurologic disorders including the other form of familial periodic ataxia also result from defects in brain ion channels. A feature shared by all of the known ion channel disorders is responsiveness to acetazolamide.
21. Blakley BW: A randomized, controlled assessment of the canalith repositioning maneuver. Otolaryngol Head Neck Surg 1994, 110:391-396.
22. Baloh RW, Jacobson K, Honrubia V: Horizontal semicircular canal variant of benign positional vertigo. Neurology 1993, 43:2542-2549.
23. Baloh RW, Yue Q, Jacobson KM, Honrubia V: Persistent direction-changing positional nystagmus: Another variant of benign positional nystagmus? Neurology 1995, 45:1297-1301. A form of positional nystagmus commonly attributed to central lesions was shown to be a variant of benign positional nystagmus. Both geotropic and ageotropic positional nystagmus can result from abnormal debris within the horizontal semicircular canal.
24. Lempert T: Horizontal benign positional vertigo [Letter]. Neurology 1994, 44:2213-2214.